LifeQ, an Atlanta, GA-based provider of biometrics and health information derived from wearable devices and used in health management solutions, secured $47m in funding.
Backers included Invenfin, 4Di Capital, Allectus Capital, Mogul Capital, Tenhong Holdings, Analog Devices, Hannover Re, Convergence Partners, Stellar Capital Partners, Nedbank Corporate and Investment Bank, Delos, OneBio Seed Investment Fund, Virgin Group, Lireas, Allen & Co, and Acequia Capital, as well as family offices such as Rachel Diamond, Halls Investments, Bremer Investments, Errol Damelin, Dietco, among others.
Co-founded by Laurence Olivier, CEO, and Dr. Franco du Preez, Chief Scientist, LifeQ is a provider of biometrics and health insights derived from wearable devices. By offering a 24/7 lens into the body, LifeQ generates business-grade biometrics for consumers, athletes, and the acutely and chronically ill to detect health problems earlier, manage their existing problems, and prevent illness. The company enables wearable devices to provide business-grade and near clinical-grade health information streams and uses this data to generate health and wellness solutions for consumer, business and clinical applications. LifeQ’s GDPR-compliant solutions are used by consumers, wearable device companies, insurers and reinsurers, health-tech companies, clinicians, researchers and analytics companies.
Businesses that have incorporated LifeQ into their offerings include prominent global entities such as Samsung, Xiaomi, Fossil Group, Montblanc, Motorola, Suunto, and HannoverRe.
FinSMEs
27/05/2021